Basic Information

Gene symbol CXCL5 Synonyms ENA-78, SCYB5 Type of gene protein-coding
Gene perturbation-related omics dataset PerturbAtlas
Description C-X-C motif chemokine ligand 5

Gene symbol S Synonyms E2 Type of gene protein-coding
Gene perturbation-related omics dataset PerturbAtlas
Description spike glycoprotein

GTO ID GTC3301
Trial ID NCT05677893
Disease Severe Acute Respiratory Syndrome Coronavirus 2
Altered gene S|CXCL5
Therapeutic/Target gene Target gene
TherapysiRNA
Treatment MBS-COV|SNS812
PhasePhase1
Recruitment statusCompleted
TitleA Phase I, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single and Multiple Ascending Doses of Inhaled MBS-COV (SNS812) in Healthy Participants
Year2022
CountryUnited States
Company sponsorOneness Biotech Co., Ltd.
Other ID(s)SNS812CLCT01

Clinical Result

Cohort1: MBS-COV
Administration route inhalation
Dosage MBS-COV, 0.3-1.2 mg/kg, single or multiple doses
Age Adult
Cohort2: Placebo
Administration route None
Dosage placebo, single or multiple doses
Age Adult

Relationship Graph

Overview of Knowledge Graph